Gene · 4824
Papers3,429
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,429
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emerging implications of N6-methyladenosine in prostate cancer progression and treatment. | Cell Death Discov | 2025 | 40830264 | PubTator, text mining | PubMed |
| Gastric Cancer Metastasis to the Prostate Detected on 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT): A Report of a Rare Case. | Cureus | 2025 | 40821321 | PubTator, text mining | PubMed |
| Case Report: Personalized peptide-based immunization in an advanced-stage prostate cancer patient with bone metastasis. | Front Oncol | 2025 | 40766334 | PubTator, text mining | PubMed |
| A Promising Breakthrough for Triple-Negative Breast Cancer by Targeting the AKT and EZH2. | MedComm (2020) | 2025 | 40766180 | PubTator, text mining | PubMed |
| Fumarate hydratase-deficient renal cell carcinoma with sarcomatoid features: a case report. | AME Case Rep | 2025 | 40761212 | PubTator, text mining | PubMed |
| AR to GR switch modulates differential TDO2-Kyn-AhR signalling to promote the survival and recurrence of treatment-induced dormant cells in prostate cancer. | Cell Discov | 2025 | 40759641 | PubTator, text mining | PubMed |
| Case Report: Solitary adrenal metastasis from esophageal adenocarcinoma. | Front Med (Lausanne) | 2025 | 40747093 | PubTator, text mining | PubMed |
| New Insights into Potential Therapeutic Targets for Neuroendocrine Prostate Cancer: From Bench to Clinic. | Research (Wash D C) | 2025 | 40746825 | PubTator, text mining | PubMed |
| Sex-specific DNA methylation associations with circulating urate levels and BCG-induced urate changes. | Commun Med (Lond) | 2025 | 40745483 | PubTator, text mining | PubMed |
| Impact of hormone sensitivity status on aberrant expression of CK7, CK20, CDX2, GATA3 and TTF1 in prostate cancer. | Hum Pathol | 2025 | 40714131 | PubTator, text mining | PubMed |
| Genetic Analysis of Osteosarcoma Cells in a 9-year-old Boy: Genes Involved in Cell Cycle Control. | Acta Med Acad | 2025 | 40693640 | PubTator, text mining | PubMed |
| EWSR1::NFATC2 Rearranged Sarcoma : Distinct Clinicopathological Features From a Series of 5 Rare Cases. | Appl Immunohistochem Mol Morphol | 2025 | 40693581 | PubTator, text mining | PubMed |
| Use of Droplet Digital PCR for Consistent Detection of TMPRSS2:ERG Gene Fusion Transcripts Initiated In Vitro. | Prostate | 2025 | 40641430 | PubTator, text mining | PubMed |
| Pediatric mesenchymal chondrosarcoma with archetypal histology in the absence of HEY1::NCOA2 gene fusion: a molecular-morphological paradox. | Oral Oncol | 2025 | 40614571 | PubTator, text mining | PubMed |
| Deletions of LPL and NKX3.1 in Prostate Cancer Progression: Game Changers or By-Standers in Tumor Evolution. | Biomolecules | 2025 | 40563400 | PubTator, text mining | PubMed |
| A Novel Primary Cell Line Model of Localized Prostate Cancer and Radioresistance-A Role for Nicotinamide N-Methyltransferase. | Cells | 2025 | 40497995 | PubTator, text mining | PubMed |
| Single-cell analysis reveals potential therapeutic markers of peripheral blood mononuclear cells from bladder cancer patients. | Braz J Med Biol Res | 2025 | 40367012 | PubTator, text mining | PubMed |
| Association Aamong Ppolymorphisms in the Aapoptosis-Rrelated NKX3-1, Caspase-3, Caspase-9, and BCL-2 Genes and Prostate Cancer Susceptibility From 9706 Cases and 12,567 Controls. | Cancer Rep (Hoboken) | 2025 | 40344485 | PubTator, text mining | PubMed |
| Metastatic Prostatic Adenocarcinoma to the Penis with Diffuse P16 Expression: Recognizing a Diagnostic Pitfall. | Pathobiology | 2025 | 40254018 | PubTator, text mining | PubMed |
| Editorial: State-of-the-art hypothesis-driven systems pharmacology and artificial intelligence approaches to decipher disease complexity. | Front Pharmacol | 2025 | 40206057 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4824/papers?page=6